News & Updates
Filter by Specialty:
Dapagliflozin prevents worsening heart failure, CV death
06 Oct 2022
Dapagliflozin is a safe treatment to reduce the risk of worsening heart failure (HF) or cardiovascular death both in patients with and without history of recent HF hospitalization, a study has shown.
Dapagliflozin prevents worsening heart failure, CV death
06 Oct 2022Trans fatty acid intake tied to hypertensive disorders of pregnancy
05 Oct 2022
Prepregnancy intakes of total fat, unsaturated fat, and monounsaturated fatty acid (MUFA) do not appear to contribute to hypertensive disorders of pregnancy (HDP), but trans fatty acid (TFA) shows a positive association with HDP, reports a study.
Trans fatty acid intake tied to hypertensive disorders of pregnancy
05 Oct 2022Bashir catheter shows treatment potential for pulmonary embolism
05 Oct 2022
byAudrey Abella
Pharmacomechanical catheter-directed thrombolysis (PM-CDT) using the Bashir endovascular catheter demonstrated potential for the treatment of intermediate-risk acute pulmonary embolism (PE), findings from the RESCUE* trial have shown.